Sonoma Pharmaceuticals, Inc. (SNOA) Balance Sheet
SNOA balance sheet, FY2026
March 31, 2026 · U.S. dollars$14.0M assets = $10.9M liabilities + $3.1M equity
Both columns are drawn to the same scale: what SNOA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SNOA financial health
Descriptive bands, not a rating. Fiscal FY2026.
SNOA balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $25.5MFY2017 | $14.0MFY2026 | −6.5%/yr | |
| Total liabilities | $4.0MFY2017 | $10.9MFY2026 | +11.7%/yr | |
| Shareholders’ equity | $21.4MFY2017 | $3.1MFY2026 | −19.3%/yr | |
| Cash & short-term investments | $17.5MFY2017 | $2.4MFY2026 | −19.8%/yr | |
| Total debt | $410,000FY2017 | $842,000FY2026 | +8.3%/yr | |
| Net cash (debt) | $17.1MFY2017 | $1.6MFY2026 | −$15.5M | |
| Working capital | $19.4MFY2017 | $7.3MFY2026 | −$12.1M | |
| Book value per share | $3.55FY2025 | $1.84FY2026 | −48.3%/yr | |
| Current ratio | 6.89FY2017 | 2.50FY2026 | −4.38 | |
| Debt / equity | 0.02FY2017 | 0.27FY2026 | +0.25 | |
| Shares outstanding | 1.2MFY2025 | 1.7MFY2026 | +35.7%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SNOA assets
SNOA liabilities and equity
SNOA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SNOA balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $2.4M | $5.4M | $3.1M | $3.8M | $7.4M | $4.2M | $3.7M | $3.7M | $10.1M | $17.5M |
| Cash & equivalents | $2.4M | $5.4M | $3.1M | $3.8M | $7.4M | $4.2M | $3.7M | $3.7M | $10.1M | $17.5M |
| Short-term investments | — | — | — | — | — | — | — | — | $0 | $0 |
| Receivables | $5.4M | $3.8M | $6.0M | $2.6M | $2.4M | $2.8M | $4.0M | $3.5M | $1.5M | $2.1M |
| Inventory | $3.7M | $2.9M | $2.7M | $2.9M | $2.7M | $2.5M | $2.2M | $3.4M | $2.9M | $2.2M |
| Other current assets | $615,000 | $596,000 | $707,000 | $4.5M | $4.0M | $3.2M | $2.5M | $1.9M | $1.8M | $853,000 |
| Total current assets | $12.1M | $12.6M | $12.5M | $13.8M | $16.4M | $12.8M | $12.4M | $12.5M | $16.3M | $22.6M |
| Property, plant & equipment (net) | $912,000 | $309,000 | $651,000 | $906,000 | $879,000 | $1.1M | $1.3M | $727,000 | $1.1M | $1.2M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $948,000 | $736,000 | $1.5M | $1.5M | $1.5M | $1.1M | $850,000 | $1.2M | $1.8M | $1.6M |
| Total assets | $14.0M | $13.7M | $14.7M | $16.2M | $18.8M | $15.0M | $14.6M | $14.4M | $19.2M | $25.5M |
| Liabilities | ||||||||||
| Accounts payable | $1.9M | $953,000 | $607,000 | $841,000 | $1.6M | $1.8M | $2.1M | $1.3M | $1.3M | $1.3M |
| Short-term debt | $373,000 | $278,000 | $521,000 | $687,000 | $1.1M | $836,000 | $615,000 | $463,000 | $377,000 | $197,000 |
| Deferred revenue | $284,000 | $641,000 | $478,000 | $160,000 | $1.3M | $319,000 | $273,000 | $102,000 | $206,000 | $521,000 |
| Total current liabilities | $4.8M | $4.1M | $3.7M | $3.7M | $5.8M | $4.1M | $4.7M | $3.6M | $3.3M | $3.3M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $1.3M | $0 | $12,000 | $176,000 | $213,000 |
| Lease obligations | $620,000 | $85,000 | $285,000 | $418,000 | $559,000 | $769,000 | $997,000 | $141,000 | $144,000 | $168,000 |
| Other long-term liabilities | $6.0M | $5.2M | $4.9M | $4.5M | $4.3M | $4.2M | $4.2M | $356,000 | $443,000 | $527,000 |
| Total liabilities | $10.9M | $9.3M | $8.6M | $8.3M | $10.1M | $9.6M | $8.9M | $4.0M | $3.9M | $4.0M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | — | — | $2,000 | $5,000 | $2,000 | $2,000 | $2,000 | $2,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$201.0M | −$197.8M | −$194.3M | −$189.5M | −$184.4M | −$179.3M | −$175.3M | −$169.2M | −$157.4M | −$143.1M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$3.2M | −$4.4M | −$2.7M | −$3.4M | −$4.3M | −$4.6M | −$5.6M | −$4.3M | −$4.0M | −$4.2M |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $3.1M | $4.4M | $6.1M | $8.0M | $8.7M | $5.4M | $5.6M | $10.5M | $15.3M | $21.4M |
| Key figures | ||||||||||
| Total debt | $842,000 | $305,000 | $608,000 | $849,000 | $1.4M | $2.7M | $850,000 | $475,000 | $553,000 | $410,000 |
| Net cash (debt) | $1.6M | $5.1M | $2.5M | $3.0M | $6.0M | $1.5M | $2.8M | $3.2M | $9.5M | $17.1M |
| Working capital | $7.3M | $8.6M | $8.8M | $10.1M | $10.6M | $8.7M | $7.7M | $8.9M | $13.0M | $19.4M |
| Tangible book value | $3.1M | $4.4M | $6.1M | $8.0M | $8.7M | $5.4M | $5.6M | $10.5M | $15.3M | $21.4M |
| Book value per share | $1.84 | $3.55 | — | — | — | — | — | — | — | — |
| Shares outstanding | 1.7M | 1.2M | — | — | — | — | — | — | — | — |
| Current ratio | 2.50 | 3.09 | 3.37 | 3.71 | 2.82 | 3.13 | 2.62 | 3.48 | 4.98 | 6.89 |
| Quick ratio | 1.62 | 2.23 | 2.45 | 1.72 | 1.68 | 1.72 | 1.62 | 2.00 | 3.56 | 5.95 |
| Debt / equity | 0.27 | 0.07 | 0.10 | 0.11 | 0.16 | 0.50 | 0.15 | 0.05 | 0.04 | 0.02 |
| Equity / assets | 22.2% | 32.2% | 41.6% | 49.1% | 46.2% | 35.8% | 38.6% | 72.6% | 79.8% | 84.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $5.3M | $2.4M | $2.6M | $3.0M | $3.6M | $5.4M | $5.2M | $4.1M | $2.6M | $3.1M | $2.4M | $2.1M |
| Cash & equivalents | $5.3M | $2.4M | $2.6M | $3.0M | $3.6M | $5.4M | $5.2M | $4.1M | $2.6M | $3.1M | $2.4M | $2.1M |
| Receivables | $3.2M | $5.4M | $2.4M | $2.7M | $2.6M | $3.8M | $2.4M | $3.2M | $3.2M | $6.0M | $2.9M | $2.2M |
| Inventory | $3.8M | $3.7M | $3.7M | $3.6M | $3.8M | $2.9M | $3.1M | $2.8M | $2.7M | $2.7M | $3.0M | $2.5M |
| Other current assets | $4.0M | $615,000 | $3.5M | $3.1M | $3.1M | $596,000 | $1.6M | $2.1M | $3.4M | $707,000 | $4.0M | $4.4M |
| Total current assets | $16.3M | $12.1M | $12.1M | $12.5M | $13.1M | $12.6M | $12.4M | $12.2M | $11.9M | $12.5M | $12.2M | $11.3M |
| Property, plant & equipment (net) | $868,000 | $912,000 | $956,000 | $763,000 | $837,000 | $309,000 | $334,000 | $417,000 | $518,000 | $651,000 | $738,000 | $783,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $971,000 | $948,000 | $522,000 | $592,000 | $650,000 | $736,000 | $954,000 | $1.0M | $1.2M | $1.5M | $1.6M | $1.6M |
| Total assets | $18.1M | $14.0M | $13.6M | $13.9M | $14.6M | $13.7M | $13.7M | $13.7M | $13.7M | $14.7M | $14.6M | $13.6M |
| Liabilities | ||||||||||||
| Accounts payable | $2.2M | $1.9M | $1.6M | $1.4M | $2.0M | $953,000 | $1.4M | $770,000 | $751,000 | $607,000 | $864,000 | $987,000 |
| Short-term debt | $300,000 | $373,000 | $146,000 | $144,000 | $235,000 | $278,000 | $90,000 | $198,000 | $359,000 | $521,000 | $225,000 | $388,000 |
| Deferred revenue | $282,000 | $284,000 | $314,000 | $750,000 | $731,000 | $641,000 | $302,000 | $319,000 | $413,000 | $478,000 | $138,000 | $162,000 |
| Total current liabilities | $5.4M | $4.8M | $4.2M | $4.3M | $4.8M | $4.1M | $3.7M | $3.3M | $3.8M | $3.7M | $3.1M | $3.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $599,000 | $620,000 | $655,000 | $479,000 | $536,000 | $85,000 | $119,000 | $162,000 | $216,000 | $285,000 | $341,000 | $350,000 |
| Other long-term liabilities | $6.1M | $6.0M | $6.0M | $5.7M | $5.7M | $5.2M | $5.1M | $5.0M | $4.9M | $4.9M | $4.9M | $4.7M |
| Total liabilities | $11.5M | $10.9M | $10.2M | $10.1M | $10.5M | $9.3M | $8.8M | $8.3M | $8.7M | $8.6M | $7.9M | $8.0M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | — | — | — | — | — | — | — | — | $2,000 | $2,000 | $2,000 | $1,000 |
| Retained earnings (deficit) | −$201.3M | −$201.0M | −$200.4M | −$199.6M | −$199.0M | −$197.8M | −$197.0M | −$196.1M | −$195.5M | −$194.3M | −$193.3M | −$192.4M |
| Accumulated other comprehensive income | −$3.0M | −$3.2M | −$3.2M | −$3.4M | −$3.6M | −$4.4M | −$4.6M | −$4.2M | −$3.6M | −$2.7M | −$2.8M | −$3.1M |
| Total shareholders' equity | $6.6M | $3.1M | $3.4M | $3.8M | $4.1M | $4.4M | $4.9M | $5.4M | $5.0M | $6.1M | $6.7M | $5.7M |
| Key figures | ||||||||||||
| Total debt | $739,000 | $842,000 | $655,000 | $535,000 | $675,000 | $305,000 | $119,000 | $244,000 | $420,000 | $608,000 | $385,000 | $522,000 |
| Net cash (debt) | $4.6M | $1.6M | $1.9M | $2.5M | $2.9M | $5.1M | $5.1M | $3.8M | $2.2M | $2.5M | $2.0M | $1.6M |
| Working capital | $10.8M | $7.3M | $7.9M | $8.2M | $8.3M | $8.6M | $8.7M | $8.9M | $8.2M | $8.8M | $9.2M | $8.0M |
| Tangible book value | $6.6M | $3.1M | $3.4M | $3.8M | $4.1M | $4.4M | $4.9M | $5.4M | $5.0M | $6.1M | $6.7M | $5.7M |
| Book value per share | $1.71 | $1.75 | $2.00 | $2.30 | $2.47 | $3.55 | $3.33 | $5.18 | — | — | — | — |
| Shares outstanding | 3.8M | 1.8M | 1.7M | 1.6M | 1.6M | 1.2M | 1.5M | 1.0M | — | — | — | — |
| Current ratio | 2.99 | 2.50 | 2.88 | 2.89 | 2.70 | 3.09 | 3.34 | 3.69 | 3.18 | 3.37 | 3.98 | 3.48 |
| Quick ratio | 1.56 | 1.62 | 1.17 | 1.33 | 1.28 | 2.23 | 2.06 | 2.19 | 1.56 | 2.45 | 1.72 | 1.35 |
| Debt / equity | 0.11 | 0.27 | 0.19 | 0.14 | 0.17 | 0.07 | 0.02 | 0.05 | 0.08 | 0.10 | 0.06 | 0.09 |
| Equity / assets | 36.4% | 22.2% | 25.2% | 27.3% | 27.8% | 32.2% | 35.6% | 39.1% | 36.4% | 41.6% | 45.8% | 41.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed June 16, 2026); data from EODHD.
SNOA financial position
At the end of fiscal 2026 (March 31, 2026), Sonoma Pharmaceuticals had total assets of $14.0 million (up 1.9% from a year earlier), total liabilities of $10.9 million and shareholders' equity of $3.1 million. It held $2.4 million in cash and short-term investments against $0.8 million of debt, a net cash position of $1.6 million. Its current ratio was 2.50. In the latest quarter (ended June 30, 2026) total assets were $18.1 million and equity $6.6 million.
Related: SNOA income statement, SNOA cash flow statement, SNOA key metrics. See the SNOA stock overview for the latest quote and news.
SNOA balance sheet FAQ
What are Sonoma Pharmaceuticals's total assets?
Sonoma Pharmaceuticals reported total assets of $14.0 million at the end of fiscal 2026 (March 31, 2026), compared with $13.7 million a year earlier.
How much debt does Sonoma Pharmaceuticals have?
Sonoma Pharmaceuticals had $0.8 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.27.
How much cash does Sonoma Pharmaceuticals have?
Sonoma Pharmaceuticals held $2.4 million in cash and short-term investments at the end of fiscal 2026; with $0.8 million of debt that is net cash of $1.6 million.
What is Sonoma Pharmaceuticals's book value?
Sonoma Pharmaceuticals's shareholders' equity (book value) was $3.1 million at the end of fiscal 2026, or $1.84 per share.
What is Sonoma Pharmaceuticals's current ratio?
Sonoma Pharmaceuticals had current assets of $12.1 million and current liabilities of $4.8 million, a current ratio of 2.50 (it can cover its short-term obligations).